James Hambro & Partners LLP Purchases 2,898 Shares of Intuitive Surgical, Inc. $ISRG

James Hambro & Partners LLP boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% during the third quarter, Holdings Channel reports. The firm owned 236,545 shares of the medical equipment provider’s stock after acquiring an additional 2,898 shares during the quarter. Intuitive Surgical makes up about 3.8% of James Hambro & Partners LLP’s investment portfolio, making the stock its 15th biggest position. James Hambro & Partners LLP’s holdings in Intuitive Surgical were worth $105,784,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Brighton Jones LLC raised its holdings in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Axiom Investors LLC DE purchased a new position in Intuitive Surgical during the 1st quarter valued at about $76,559,000. Campbell & CO Investment Adviser LLC lifted its position in Intuitive Surgical by 125.4% during the 1st quarter. Campbell & CO Investment Adviser LLC now owns 3,778 shares of the medical equipment provider’s stock valued at $1,871,000 after acquiring an additional 2,102 shares during the period. Synovus Financial Corp boosted its stake in Intuitive Surgical by 36.9% during the first quarter. Synovus Financial Corp now owns 3,492 shares of the medical equipment provider’s stock worth $1,729,000 after acquiring an additional 941 shares in the last quarter. Finally, J. Stern & Co. LLP purchased a new stake in Intuitive Surgical in the first quarter worth about $2,363,000. Institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other Intuitive Surgical news, EVP Myriam Curet sold 104 shares of the firm’s stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $559.90, for a total value of $58,229.60. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Craig H. Barratt sold 750 shares of the company’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $435,000.00. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 114,007 shares of company stock valued at $63,533,844 over the last ninety days. 0.70% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of analyst reports. Rothschild & Co Redburn boosted their price target on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. Jefferies Financial Group raised their price target on Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a report on Wednesday, October 22nd. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $685.00 target price on shares of Intuitive Surgical in a report on Tuesday, October 21st. Finally, Truist Financial increased their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Two analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $611.08.

Intuitive Surgical Stock Down 0.4%

Shares of NASDAQ ISRG opened at $577.34 on Wednesday. The firm’s 50-day moving average price is $547.18 and its 200-day moving average price is $505.91. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The company has a market cap of $206.96 billion, a PE ratio of 76.37, a PEG ratio of 5.33 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the prior year, the firm earned $1.84 earnings per share. The firm’s revenue for the quarter was up 22.9% compared to the same quarter last year. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.